Do Not Prescribe Cough Medications for Nighttime Cough in a 10-Year-Old
Over-the-counter cough and cold medicines should not be prescribed for children with acute cough, as they have not been shown to make cough less severe or resolve sooner, and they carry risks of adverse events including death from toxicity. 1
Evidence-Based Approach
First-Line Recommendation: Honey
- Honey may offer more relief for cough symptoms than no treatment, diphenhydramine, or placebo (though not superior to dextromethorphan) 1
- This is the only treatment with evidence of benefit and an acceptable safety profile
- Appropriate for children over 1 year of age
What NOT to Prescribe
Avoid codeine-containing medications due to potential for serious side effects including respiratory distress 1. The FDA altered labeling in 2018 to limit prescription opioid cough medicines to adults ≥18 years only 1.
Do not prescribe OTC cough medications containing:
- Antihistamines (minimal to no efficacy in children, associated with adverse events) 1
- Dextromethorphan (associated with adverse events, no proven superiority to placebo) 1
- Decongestants (lack of efficacy, potential harm) 1
Research confirms this: A 2013 RCT showed dextromethorphan and promethazine were not superior to placebo for nocturnal cough in children with URI 2, and a 1993 study found neither codeine nor dextromethorphan was more effective than placebo 3.
Clinical Algorithm for Evaluation
Determine Duration and Type of Cough
If cough duration < 2-4 weeks (acute cough):
- Likely viral upper respiratory infection
- Recommend honey for symptomatic relief
- Reassure that nocturnal cough in URI is self-resolving 2
If cough persists > 2-4 weeks (chronic cough):
- Re-evaluate for specific etiological pointers 1
- Look for "red flags": wheeze, crepitations, abnormal chest radiograph, failure to thrive, dysphagia, recurrent pneumonia
Assess for Asthma Risk Factors
If risk factors for asthma are present (family history, atopy, wheeze, exercise-induced symptoms):
- Consider a short 2-4 week trial of inhaled corticosteroids (400 mcg/day beclomethasone equivalent) 1
- Must re-evaluate in 2-4 weeks - if no response, stop the medication
- Cough unresponsive to ICS should not be treated with increased doses 1
Rule Out Other Specific Causes
Check for GERD symptoms:
- Do NOT treat for GERD if no clinical features present (recurrent regurgitation, heartburn/epigastric pain) 4
- Acid suppressive therapy should not be used solely for chronic cough 4
Consider obstructive sleep apnea (OSA):
- If suspected, manage according to sleep guidelines 1
Critical Pitfalls to Avoid
Do not use "trial of therapy" approach with cough suppressants - there is no evidence they work and they carry risks 1
Do not continue ineffective treatments - if medications are used (e.g., ICS for suspected asthma), children must be followed up and medications ceased if no effect within expected timeframe 1
Do not assume cough resolution with ICS means asthma - may be spontaneous resolution or transient effect; re-evaluate off treatment 1
Recognize that cough should be treated based on etiology, not symptomatically - there is no evidence for using medications for symptomatic relief of cough in children 1
The Bottom Line
The 2020 CHEST guidelines are unequivocal: cough in children should be treated based on etiology, and there is no evidence for using medications for symptomatic relief of cough 1. The only exception is honey for acute cough. OTC medications have little if any benefit but importantly are associated with adverse events, including reported deaths from toxicity in young children 1.